2014
DOI: 10.1016/j.freeradbiomed.2014.06.008
|View full text |Cite
|
Sign up to set email alerts
|

Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
50
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(53 citation statements)
references
References 53 publications
1
50
0
Order By: Relevance
“…Curiously, no significant difference was attained for SFN treatment at the same dose. Taken together, although results from cyclin A2 analysis (Figure 4B) did not confirm the G 2 /M cell cycle arrest results (Figure 4A), they could be related with the DNA-damaging abilities of both ITCs [56,57,58,59] and with DNA double-strand-breaks repair by homologous recombination [60,61]. In agreement, increased Cyclin A expression levels have previously been shown in HT29 monolayers treated with SFN [50].…”
Section: Resultsmentioning
confidence: 74%
“…Curiously, no significant difference was attained for SFN treatment at the same dose. Taken together, although results from cyclin A2 analysis (Figure 4B) did not confirm the G 2 /M cell cycle arrest results (Figure 4A), they could be related with the DNA-damaging abilities of both ITCs [56,57,58,59] and with DNA double-strand-breaks repair by homologous recombination [60,61]. In agreement, increased Cyclin A expression levels have previously been shown in HT29 monolayers treated with SFN [50].…”
Section: Resultsmentioning
confidence: 74%
“…It has been previously suggested that electrophilic small molecules such as buthionine sulfoximine (BSO), piperlongumine (PL), and phenethyl isothiocyanate (PEITC) convey at least part of their toxicity via this mechanism (9,16,39,49,51,56), and all of these drugs have been shown to be selectively toxic to certain in vitro and in vivo tumor models (1,5,13,39). Incubation of tumor cells with piperlongumine and PEITC results in depletion of GSH and elevation of fluorescence from dichloro-dihydro-fluorescein diacetate (DCFH-DA), a cell permeable dye that exhibits increasing fluorescence intensity upon oxidation (9,39,49,56). However, recent comprehensive studies involving a broader class of small molecules suggest that the depletion of GSH is often insufficient to induce death of tumor cells.…”
Section: Innovationmentioning
confidence: 99%
“…One of the mechanisms of piperlongumine and PEITC toxicity suggested by previous studies is the depletion of the total GSH level and the subsequent increase in oxidative stress (5,9,39,49,56). We used a specific, small-molecule inhibitor of GSH synthesis, BSO, as a control for determining whether the level of depletion in the two compounds is an important contributor to tumor inhibition (57).…”
Section: Differential Response Of Hela and A549 Cells To Piperlongumimentioning
confidence: 99%
“…11 Previous studies have demonstrated that PEITC killed malignant cancer cells by disabling glutathione (GSH) antioxidant system and disrupting redox-sensitive survival pathways. 10, 12 Moreover, PEITC has been registered in clinical trials for cancer prevention and treatment (ClinicalTrials.gov Identifiers: NCT00005883, NCT00691132 and NCT01790204), indicating that PEITC could hold a therapeutic promise to treat cancer patients. In our recent work, using PEITC as the lead compound, a series of small molecular analogs of PEITC were designed and synthesized in order to discover more potent ROS modulator with better anticancer capacity (data not shown).…”
mentioning
confidence: 99%